The Emerging Spectrum of COVID-19 Neurology
In the recently published in the Brain article, The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings, the authors, Ross W Paterson and colleagues, presented preliminary clinical data indicating that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness.
The authors found that “SARS-CoV-2 infection is associated with a wide spectrum of neurological syndromes affecting the whole neuraxis, including the cerebral vasculature and, in some cases, responding to immunotherapies. The high incidence of acute disseminated encephalomyelitis, particularly with haemorrhagic change, is striking. This complication was not related to the severity of the respiratory COVID-19 disease.”